Loading clinical trials...
Loading clinical trials...
FOCUS (Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol) is a Phase 3, multi-center, randomized, double-blind, placebo-controlled, parallel- group trial to assess the effica...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Axsome Therapeutics, Inc.
NCT07478458 · ADHD - Attention Deficit Disorder With Hyperactivity
NCT05842330 · ADHD
NCT07465081 · ADD/ADHD
NCT06655610 · ADHD - Attention Deficit Disorder With Hyperactivity
NCT06810180 · Attention Deficit Hyperactivity Disorder (ADHD), Sleep, and more
Clinical Research Site
Encino, California
Clinical Research Site
Garden Grove, California
Clinical Research Site
Newport Beach, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions